| | Commentaries The Myocardial Ischemia Reduction with Acute Cholesterol Lowering trial: MIRACuLous or not, it's time to change current practice Herbert D Aronow PMCID: PMC134475 Pooling, meta-analysis, and the evaluation of drug safety Michel Lièvre, Michel Cucherat, and Alain Leizorovicz PMCID: PMC134478 Reviews Clinical significance of cardiovascular dysmetabolic syndrome Prakash C Deedwania PMCID: PMC134474 Problems in dealing with missing data and informative censoring in clinical trials Weichung Joseph Shih PMCID: PMC134476 A Review of the Adverse Effects of Peripheral Alpha-1 Antagonists in Hypertension Therapy Chris L Bryson, MD and Bruce M Psaty, MD PhD PMCID: PMC134479 Research Weight-modification trials in older adults: what should the outcome measure be? Paula Diehr, Anne B Newman, Sharon A Jackson, Lewis Kuller, and Neil Powe PMCID: PMC134473 Long-term vitamin E supplementation fails to reduce lipid peroxidation in people at cardiovascular risk: analysis of underlying factors Chiara Chiabrando, Fausto Avanzini, Claudia Rivalta, Fabio Colombo, Roberto Fanelli, Gaetana Palumbo, Maria Carla Roncaglioni, and PPP Collaborative Group on the antioxidant effect of vitamin E PMCID: PMC134477 A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics Ian Ford, Gerard Jan Blauw, Michael B Murphy, James Shepherd, Stuart M Cobbe, Edward LEM Bollen, Brendan M Buckley, J Wouter Jukema, Michael Hyland, Allan Gaw, A Margot Lagaay, Ivan J Perry, Peter Macfarlane, John Norrie, A Edo Meinders, Brian J Sweeney, Chris J Packard, Rudi GJ Westendorp, Cillian Twomey, David J Stott, and the PROSPER Study Group PMCID: PMC134480 A randomized controlled trial of an extensive lifestyle management intervention (ELMI) following cardiac rehabilitation: study design and baseline data Scott A Lear, Andrew Ignaszewski, Wolfgang Linden, Anka Brozic, Marla Kiess, John J Spinelli, P Haydn Pritchard, and Jiri J Frohlich PMCID: PMC149404 Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone Linda B Piller, Barry R Davis, Jeffrey A Cutler, William C Cushman, Jackson T Wright, Jr, Jeff D Williamson, Frans HH Leenen, Paula T Einhorn, Otelio S Randall, John S Golden, L Julian Haywood, and the ALLHAT Collaborative Research Group PMCID: PMC149403 |
